 <h1>Wellcovorin Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>leucovorin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about leucovorin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Wellcovorin.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to leucovorin: powder for solution, solution, tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, leucovorin (the active ingredient contained in Wellcovorin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking leucovorin:</p><p>
<i>Rare</i>
</p><ul>
<li>Skin rash, hives, or itching</li>
<li>wheezing </li>
</ul><p>Check with your doctor as soon as possible if any of the following side effects occur while taking leucovorin:</p><p>
<i>Rare</i>
</p><ul>
<li>Convulsions (seizures)</li>
</ul><p>
<!-- end powder for solution, solution, tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to leucovorin: compounding powder, injectable powder for injection, injectable solution, oral tablet</i></p><h3>General</h3><p>Adverse events attributed to use of leucovorin (the active ingredient contained in Wellcovorin) folinic acid by itself include allergic sensitization, including anaphylactoid reactions and urticaria; gastrointestinal and hematologic adverse events were common when used with fluorouracil.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Stomatitis (75%, when used with fluorouracil), nausea (74%, when used with fluorouracil), diarrhea (66%, when used with fluorouracil), vomiting (46%, when used with fluorouracil), dehydration (when used with fluorouracil) </p>
<p><b>Common</b> (1% to 10%): Constipation (when used with fluorouracil)</p>
<p><b>Rare</b> (less than 0.1%): Gastrointestinal disorders (after high doses)</p>
<p><b>Frequency not reported</b>: Mucositis (when used with fluorouracil), cheilitis (when used with fluorouracil)<sup>[Ref]</sup></p><p>When used with fluorouracil, diarrhea and dehydration have resulted in hospital admission and death.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Leucopenia (69%, when used with fluorouracil)</p>
<p><b>Common</b> (1% to 10%): Thrombocytopenia (when used with fluorouracil)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Allergic reactions (sensitization, including anaphylactoid reactions, shock, and urticaria)</p>
<p><b>Frequency not reported</b>: Stevens Johnson Syndrome and Toxic Epidermal Necrolysis (in combination with other agents)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (42%, when used with fluorouracil), dermatitis (21%, when used with fluorouracil)</p>
<p><b>Frequency not reported</b>: Palmar-plantar erythrodysesthesia (when used with fluorouracil)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Lethargy/malaise/fatigue (13%, when used with fluorouracil)</p>
<p><b>Uncommon</b> (0.1% to 1%): Pyrexial reactions (following parenteral administration)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (14%, when used with fluorouracil)</p>
<p><b>Frequency not reported</b>: Hyperammonemia (when used with fluorouracil)</p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Infection (when used with fluorouracil)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Rare</b> (less than 0.1%): Increase in the frequency of attacks in epileptics, seizures, syncope<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Rare</b> (less than 0.1%): Insomnia, agitation, depression<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Leucovorin Calcium (leucovorin)." Epic Pharma LLC, Laurelton, NY. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Wellcovorin (leucovorin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: antidotes</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Anemia, Megaloblastic</li>
<li>Colorectal Cancer</li>
<li>Folic Acid Antagonist Overdose</li>
<li>Methotrexate Overdosage</li>
<li data-more-config-id="list-data-resources-conditions">... +5 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to leucovorin: compounding powder, injectable powder for injection, injectable solution, oral tablet</i></p><h3>General</h3><p>Adverse events attributed to use of leucovorin (the active ingredient contained in Wellcovorin) folinic acid by itself include allergic sensitization, including anaphylactoid reactions and urticaria; gastrointestinal and hematologic adverse events were common when used with fluorouracil.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Stomatitis (75%, when used with fluorouracil), nausea (74%, when used with fluorouracil), diarrhea (66%, when used with fluorouracil), vomiting (46%, when used with fluorouracil), dehydration (when used with fluorouracil) </p><p><b>Common</b> (1% to 10%): Constipation (when used with fluorouracil)</p><p><b>Rare</b> (less than 0.1%): Gastrointestinal disorders (after high doses)</p><p><b>Frequency not reported</b>: Mucositis (when used with fluorouracil), cheilitis (when used with fluorouracil)<sup>[Ref]</sup></p><p>When used with fluorouracil, diarrhea and dehydration have resulted in hospital admission and death.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Leucopenia (69%, when used with fluorouracil)</p><p><b>Common</b> (1% to 10%): Thrombocytopenia (when used with fluorouracil)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Allergic reactions (sensitization, including anaphylactoid reactions, shock, and urticaria)</p><p><b>Frequency not reported</b>: Stevens Johnson Syndrome and Toxic Epidermal Necrolysis (in combination with other agents)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (42%, when used with fluorouracil), dermatitis (21%, when used with fluorouracil)</p><p><b>Frequency not reported</b>: Palmar-plantar erythrodysesthesia (when used with fluorouracil)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Lethargy/malaise/fatigue (13%, when used with fluorouracil)</p><p><b>Uncommon</b> (0.1% to 1%): Pyrexial reactions (following parenteral administration)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (14%, when used with fluorouracil)</p><p><b>Frequency not reported</b>: Hyperammonemia (when used with fluorouracil)</p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Infection (when used with fluorouracil)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Rare</b> (less than 0.1%): Increase in the frequency of attacks in epileptics, seizures, syncope<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Rare</b> (less than 0.1%): Insomnia, agitation, depression<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Leucovorin Calcium (leucovorin)." Epic Pharma LLC, Laurelton, NY. </p><h2>More about Wellcovorin (leucovorin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: antidotes</li>
<li>FDA Alerts (1)</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Anemia, Megaloblastic</li>
<li>Colorectal Cancer</li>
<li>Folic Acid Antagonist Overdose</li>
<li>Methotrexate Overdosage</li>
<li data-more-config-id="list-data-resources-conditions">... +5 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>